The preparation derived from the cannabis plant is one of the oldest known medicinal plants, thought to have been used for thousands of years.[2] However, pharmacological research into marijuana largely began in the 1940s, which lead to the identification of the cannabinoids in marijuana and of the endogenous cannabinoid system in the brain.[2] Research into cannabis was accelerated, in part, by the increased recreational use of marijuana.[2] Cannabis dependence and withdrawal has been studied in animal models of addiction, as well as in large human population studies and cohort and self-report studies.[4] However, despite the research that has been conducted to date, approved pharmacological treatments for cannabis dependence have not proven forthcoming.[4]

References:
[1] Shahbazi F, Grandi V, Banerjee A, Trant JF. Cannabinoids and cannabinoid receptors: the story so far. iScience 2020; 23 (7): 101301.

[2] Pertwee RG. Cannabinoid pharmacology: the first 66 years. Br J Pharmacol 2006; 147 (Suppl 1): S163–171.

[3] American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 5th edition. American Psychiatric Association, 2013.

[4] Ramesh D, Schlosburg JE, Wiebelhaus JM, Lichtman AH. Marijuana dependence: not just smoke and mirrors. ILAR J 2011; 52 (3): 295–308.

[5] Maccarrone M, Maldonado R, Casas M, et al. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? Expert Rev Clin Pharmacol 2017; 10 (4): 443–455.

[6] Schlag AK, O’Sullivan SE, Zafar RR, Nutt DJ. Current controversies in medical cannabis: recent developments in human clinical applications and potential therapeutics. Neuropharmacology 2021; 191: 108586.